{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T03:20:07Z","timestamp":1791343207919,"version":"4.3.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007393","name":"Association Fran\u00c3\u00a7aise contre les Myopathies","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007393","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013414","name":"Conseil R\u00c3\u00a9gional des Pays de la Loire","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013414","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006708","name":"Appalachian Regional Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007391","name":"Association pour la Recherche sur le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007391","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.ijpharm.2011.04.067","type":"journal-article","created":{"date-parts":[[2011,5,10]],"date-time":"2011-05-10T02:07:40Z","timestamp":1304993260000},"page":"77-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["The vimentin-tubulin binding site peptide (Vim-TBS.58-81) crosses the plasma membrane and enters the nuclei of human glioma cells"],"prefix":"10.1016","volume":"423","author":[{"given":"Julien","family":"Balzeau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Eyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2011.04.067_bib0005","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1023\/A:1016136328329","article-title":"Conjugates of antisense oligonucleotides with the Tat and Antennapedia cell-penetrating peptides: effects on cellular uptake, binding to target sequences, and biologic actions","volume":"19","author":"Astriab-Fisher","year":"2002","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2011.04.067_bib0010","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.peptides.2006.12.013","article-title":"A sychnological cell penetrating peptide mimic of p21(WAF1\/CIP1) is pro-apoptogenic","volume":"28","author":"Baker","year":"2007","journal-title":"Peptides"},{"key":"10.1016\/j.ijpharm.2011.04.067_bib0015","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0960-894X(01)81162-8","volume":"1","author":"Barltrop","year":"1991","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ijpharm.2011.04.067_bib0020","doi-asserted-by":"crossref","first-page":"11043","DOI":"10.1523\/JNEUROSCI.1924-09.2009","article-title":"Neurofilaments bind tubulin and modulate its polymerization","volume":"29","author":"Bocquet","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ijpharm.2011.04.067_bib0030","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3727\/095535491820873191","article-title":"Use of an aqueous soluble tetrazolium\/formazan assay for cell growth assays in culture","volume":"3","author":"Cory","year":"1991","journal-title":"Cancer Commun."},{"key":"10.1016\/j.ijpharm.2011.04.067_bib0035","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/jcp.10029","article-title":"Growth inhibition of glioblastoma cells by human Pur alpha","volume":"189","author":"Darbinian","year":"2001","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ijpharm.2011.04.067_bib0040","doi-asserted-by":"crossref","first-page":"10444","DOI":"10.1016\/S0021-9258(17)34080-2","article-title":"The 3rd helix of the Antennapedia homeodomain translocates through biological-membranes","volume":"269","author":"Derossi","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpharm.2011.04.067_bib0045","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S1525-0016(03)00122-9","article-title":"Caveolae-mediated internalization of extracellular HIV-1 tat fusion proteins visualized in real time","volume":"8","author":"Ferrari","year":"2003","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ijpharm.2011.04.067_bib0050","doi-asserted-by":"crossref","first-page":"34141","DOI":"10.1074\/jbc.M303045200","article-title":"Cell membrane lipid rafts mediate caveolar endocytosis of HIV-1 Tat fusion proteins","volume":"278","author":"Fittipaldi","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpharm.2011.04.067_bib0055","doi-asserted-by":"crossref","first-page":"8655","DOI":"10.1073\/pnas.91.18.8655","article-title":"Cdk-interacting protein 1 directly binds with proliferating cell nuclear antigen and inhibits DNA replication catalyzed by the DNA polymerase delta holoenzyme","volume":"91","author":"Flores-Rozas","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ijpharm.2011.04.067_bib0060","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/0092-8674(88)90263-2","article-title":"Cellular uptake of the Tat protein from human immunodeficiency virus","volume":"55","author":"Frankel","year":"1988","journal-title":"Cell"},{"key":"10.1016\/j.ijpharm.2011.04.067_bib0065","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.1074\/jbc.M007540200","article-title":"Arginine-rich peptides\u2014an abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery","volume":"276","author":"Futaki","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpharm.2011.04.067_bib0075","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0092-8674(84)90006-0","article-title":"Kinetics of transit of transferrin and epidermal growth-factor through clathrin-coated membranes","volume":"39","author":"Hanover","year":"1984","journal-title":"Cell"},{"key":"10.1016\/j.ijpharm.2011.04.067_bib0080","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1476-5381.2009.00057.x","article-title":"Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics","volume":"157","author":"Heitz","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ijpharm.2011.04.067_bib0085","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1126\/science.183.4125.656","article-title":"Cholera toxin: interaction of subunits with ganglioside GM1","volume":"183","author":"Heyningen","year":"1974","journal-title":"Science"},{"key":"10.1016\/j.ijpharm.2011.04.067_bib0090","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1016\/j.biomaterials.2008.01.031","article-title":"An endosomolytic Tat peptide produced by incorporation of histidine and cysteine residues as a nonviral vector for DNA transfection","volume":"29","author":"Lo","year":"2008","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpharm.2011.04.067_bib0095","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1242\/jcs.00653","article-title":"Proliferating cell nuclear antigen (PCNA): a dancer with many partners","volume":"116","author":"Maga","year":"2003","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.ijpharm.2011.04.067_bib0100","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1083\/jcb.129.6.1509","article-title":"Oligomerized transferrin receptors are selectively retained by a lumenal sorting signal in a long-lived endocytic recycling compartment","volume":"129","author":"Marsh","year":"1995","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ijpharm.2011.04.067_bib0105","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1083\/jcb.61.3.701","article-title":"Electron-microscope and experimental investigations of neurofilamentous network in Deiters neurons\u2014relationship with cell-surface and nuclear-pores","volume":"61","author":"Metuzals","year":"1974","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ijpharm.2011.04.067_bib0110","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1093\/nar\/25.14.2730","article-title":"A new peptide vector for efficient delivery of oligonucleotides into mammalian cells","volume":"25","author":"Morris","year":"1997","journal-title":"Nucleic Acid Res."},{"key":"10.1016\/j.ijpharm.2011.04.067_bib0115","first-page":"3480","article-title":"A p21(Waf1\/Cip1) carboxyl-terminal peptide exhibited cyclin-dependent kinase-inhibitory activity and cytotoxicity when introduced into human cells","volume":"59","author":"Mutoh","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijpharm.2011.04.067_bib0120","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1021\/bc025517+","article-title":"Quantitation of the tumor-targeting properties of antibody fragments conjugated to cell-permeating HIV-1 TAT peptides","volume":"13","author":"Niesner","year":"2002","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.ijpharm.2011.04.067_bib0125","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1074\/jbc.M209548200","article-title":"Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake","volume":"278","author":"Richard","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpharm.2011.04.067_bib0130","doi-asserted-by":"crossref","first-page":"16802","DOI":"10.1021\/bi991654r","article-title":"Characterization of the nucleic acid binding region of the intermediate filament protein vimentin by fluorescence polarization","volume":"38","author":"Shoeman","year":"1999","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijpharm.2011.04.067_bib0135","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1517\/17425247.2.1.43","article-title":"Recent advances in the use of protein transduction domains for the delivery of peptides, proteins and nucleic acids in vivo","volume":"2","author":"Snyder","year":"2005","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ijpharm.2011.04.067_bib0140","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1073\/pnas.0435906100","article-title":"Cell transfection in vitro and in vivo with nontoxic TAT peptide\u2013liposome\u2013DNA complexes","volume":"100","author":"Torchilin","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ijpharm.2011.04.067_bib0145","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/S0021-9258(18)33008-4","article-title":"The interaction in vitro of the intermediate filament protein vimentin with naturally-occurring RNAs and DNAs","volume":"258","author":"Traub","year":"1983","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpharm.2011.04.067_bib0150","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/BF00778517","article-title":"Interaction in vitro of the neurofilament triplet proteins from porcine spinal-cord with natural RNA and DNA","volume":"10","author":"Traub","year":"1985","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.ijpharm.2011.04.067_bib0155","doi-asserted-by":"crossref","first-page":"16010","DOI":"10.1074\/jbc.272.25.16010","article-title":"A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus","volume":"272","author":"Vives","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpharm.2011.04.067_bib0160","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0960-9822(95)00058-3","article-title":"A small peptide inhibitor of DNA-replication defines the site of interaction between the cyclin-dependant kinase inhibitor p21(WAF1) and proliferating cell nuclear antigen","volume":"5","author":"Warbrick","year":"1995","journal-title":"Curr. Biol."},{"key":"10.1016\/j.ijpharm.2011.04.067_bib0165","doi-asserted-by":"crossref","first-page":"16026","DOI":"10.1074\/jbc.271.27.16026","article-title":"Cellular cholesterol effect mediated by cyclodextrins\u2014demonstration of kinetic pools and mechanism of efflux","volume":"271","author":"Yancey","year":"1996","journal-title":"J. Biol. Chem."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517311003942?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517311003942?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T09:27:32Z","timestamp":1759915652000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517311003942"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0378517311003942"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2011.04.067","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The vimentin-tubulin binding site peptide (Vim-TBS.58-81) crosses the plasma membrane and enters the nuclei of human glioma cells","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2011.04.067","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier B.V. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}